Week 7: Antilipidemics Flashcards

1
Q

HMG CoA Reductase Inhibitors - “statins” (Atorvastatin/Rosuvastatin) MOA

A
  • in liver, block synthesis of cholesterol by inhibiting the HMG CoA reductase activity
  • best at lowering LDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HMG CoA Reductase Inhibitors - drug interactions

A

grapefruit juice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HMG CoA reductase inhibitors cautions/ contraindications

A

- Pregnancy Category X

  • Avoid in active liver disease (bc this works in liver)
  • Avoid grapefruit juice with simvastatin, lovastatin and atorvastatin (can increase toxicity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HMG CoA reductase inhibitors ADRs

A
  • myalgias/myopathies (draw creatinine kinase to see severity of myalgia/arthalgia)– > increased CPK
  • rhabdo/metabolic acidosis: headache, fatigue, abdominal pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Statin Monitoring

A
  • check lipid levels 4 to 6 weeks after starting therapy and then every 3 to 4 months until control is established
  • baseline LFTs and then 3 to 6 months later only is suspected issues or underlying hepatic disease
  • draw CK to see severity of myalgia/arthalgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Niacin (Vitamin B3) MOA

A
  • uncertain but appears to reduce VLDL synthesis - best at increasing HDL
  • NOT recommended for hyperlipidemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Niacin cautions/ contraindications

A
  • avoid w/ hx of gout
  • avoid w/ hepatic dysfunction
  • avoid in uncontrolled diabetes (causes hyperglycemia)
  • avoid w/ active peptic ulcers
  • NO pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Niacin ADRs

A

- pruritis, flushing, hepatotoxicity (rare), rash, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Niacin Pt education

A
  • take anti-inflammatory strength NSAID/aspirin 30 minutes prior to dose to decrease ADRs (it increases prostaglandin activity which leads to flushing of head/neck and pruritis)
  • non pharm to tx hyperlipidemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fibrates (Gemfibrozil/Fenofibrate) MOA

A

**best at decreasing triglyceride levels** For high trig usually > 400 (then once its 300, switch to statins)

  • increases lipolysis of triglycerides via lipoprotein lipase –> decreases triglycerides, increase in HDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fibrates ADRs

A
  • dyspepsia, abdominal pain
  • cholelithiasis/gall stones
  • increase transaminase, diarrhea
  • increase in myalgia/arthralgia if combined with statins (DON’T combine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibrates cautions/ contraindications

A
  • avoid in liver or renal disease
  • avoid in pre-existing gallbladder disease
  • avoid in pregnancy and lactation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bile Acid Sequestrants (Cholestyramine (Questran), cholestipol, colesevelam) MOA

A
  • indirectly blocks absorption of cholesterol by forming a nonabsorbable complex (resin) with bile acids in the intestine/gut (to poop out LDL cholesterol)

- (those with liver disease can use this med but caution with other meds in gut that has narrow TI like digoxin and warfarin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bile Acid sequestrants ADRs

A

flatulence, bloating, abdominal pain, constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bile Acid sequestrants cautions/ contraindications

A
  • avoid in pts w/ elevated triglycerides >300 (can increase levels)
  • safe in pregnancy and lactation
  • avoid in pts with complete biliary obstruction
  • must take other medications and vitamins either 1 hour before or 4 hours after this medication ( can impact drug/vitamin absoprtion)

ONLY ONE SAFE FOR PREGNANGY AND LACTATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cholesterol Absorption Inhibitors (Ezetimibe/Zetia) MOA

A
  • directly blocks absorption of cholesterol across intestinal border
  • leads to a decreased delivery of cholesterol to the liver, decreased hepatic cholesterol stores, and increased clearance of cholesterol from the bloodstream
  • can safely be used with -statins
17
Q

Ezetimibe/Zetia ADRs

A
  • fatigue
  • diarrhea (greasy/tarry stools)
  • arthralgias/joint pain
  • increased serum transaminases
18
Q

Ezetimibe/Zetia cautions/contraindications

A
  • avoid in liver dz
  • avoid in pregnancy/lactation
19
Q

PCSK9 (Evolocumab/Repatha) MOA

A
  • subq injection $$$
  • human monoclonal antibody that binds to PCSK9 and inhibits the binding of PCSK9 to LDL receptors = increase LDL receptors on cell surface, decreasing LDL in bloodstream
  • 50 to 70% LDL reducation as monotherapy (can be used with statins)

Indication: for genetic disorder called familial homozygous hypercholesteremia causing their lipids to skyrocket

20
Q

PCSK9 ADRs

A
  • pain at injection site
  • anaphyslaxis/hypersensitivity rxns
21
Q

PCSK9/Repatha cautions/ contraindications

A
  • avoid in pregnancy/lactation
22
Q

Four Major Statin Benefit Groups

A
  • Group 1: nave clinical ASCVD - use high intensity statin if = 75y/o - use moderate intensity statin is > 75 y/o
  • Group 2: No ASCVD but have LDL-C levels >/= 190 - high intensity statin unless contraindication/unable to tolerate

Group 3: No ASCVD - age 40-75 w/ diabetes and LDL levels of 70-189 - moderate intensity statin if 10yr ASCVD risk is <7.5%; high intensity statin if 10yr ASCVD risk is > 7.5%

Group 4: NO ASCVD or DM; age 40-75 w/ LDL-C 70-189 and 10yr ASCVD risk >/= 7.5%- moderate intensity statin